M&A Deal Summary

KELIX Bio Acquires Pharmaceutical Institute

On March 9, 2022, KELIX Bio acquired medical products company Pharmaceutical Institute

Acquisition Highlights
  • This is KELIX Bio’s 1st transaction in the Medical Products sector.
  • This is KELIX Bio’s 1st transaction in Morocco.

M&A Deal Summary

Date 2022-03-09
Target Pharmaceutical Institute
Sector Medical Products
Buyer(s) KELIX Bio
Deal Type Add-on Acquisition

Target

Pharmaceutical Institute

Rabat, Morocco
Pharmaceutical Institute is a pharmaceutical company manufacturers and distributors of pharmaceutical products. Pharmaceutical Institute was founded in 1989 and is based in Rabat, Morocco.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

KELIX Bio

Dubai, United Arab Emirates

Category Company
Sector Life Science
DESCRIPTION

KELIX Bio is a biopharmaceutical platform specializing in generic drugs, focused on emerging markets that seeks to be competitive through innovation and cost control. KELIX Bio is based in Dubai, UAE.


DEAL STATS #
Overall 1 of 1
Sector: Medical Products M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: Morocco M&A 1 of 1
Year: 2022 M&A 1 of 1